2-bromo-N-isobutylacetamide, 95.0%, 250mg

4-Acetoxybenzaldehyde, 98.0%, 100g

Benzo[1,3]-dioxol-5-yl-hydrazine hydrochloride, 95.0%, 5g

(1S,4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 1g

L-Aspartic Acid>99.0%(T)500g

(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one, 95.0%, 5g

(1-Methylpyrrolidin-3-yl)methanol, 95.0%, 10g

3-Ethyl 4-Methyl 2-Aminothiophene-3,4-dicarboxylate>98.0%(GC)1g

n-(3-Amino-4-methoxyphenyl)methanesulfonamide, 95%, 250mg

tert-Butyl(1R,5S,8R)-8-hydroxy-3-azabicyclo[3.2.1]octane-3-carboxylate, 98%, 10g

5-Bromo-1,2-difluoro-3-(trifluoromethyl)benzene, 95.0%, 250mg

N-Carbobenzoxy-L-valine>99.0%(HPLC)(T)5g

Compact scales CX series, 0.1 g, 620 g, CX621